Stock CPT COLLPLANT BIOTECHNOLOGIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News CollPlant Biotechnologies Ltd. Deutsche Boerse AG

Equities

CPT

IL0004960188

Delayed Deutsche Boerse AG
Other stock markets
 07:02:52 17/07/2024 BST 		5-day change 1st Jan Change
4.02 EUR -3.37% Intraday chart for CollPlant Biotechnologies Ltd. -9.05% -71.08%
06-06 Collplant Successfully Bio-Prints 200Cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data CI
05-29 Earnings Flash (CLGN) COLLPLANT Reports Q1 Revenue $98,000, vs. Street Est of $650,000 MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Collplant Successfully Bio-Prints 200Cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data
CI
Earnings Flash (CLGN) COLLPLANT Reports Q1 Revenue $98,000, vs. Street Est of $650,000
MT
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update
PR
CollPlant Biotechnologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
PR
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
PR
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
PR
CollPlant Issues Letter to Shareholders
PR
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
PR
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
CI
Earnings Flash (CLGN) COLLPLANT Posts Q3 Revenue $43,000
MT
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
PR
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
PR
CollPlant Biotechnologies Issued US Patent for Photocurable Dermal Filler
MT
CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
PR
Wall Street Set to Open Slightly Higher; Weekly Jobless Claims Fall to Near Historic Lows
MT
Top Premarket Decliners
MT
CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLGN Stock
  4. CPT Stock
  5. News CollPlant Biotechnologies Ltd.